In summary, obesity’s association with AD involves complex interactions such as leptin resistance, insulin dysfunction, altered glucose metabolism, oxidative stress, amyloid-beta disturbances, and brain atrophy. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.